EP0774962 - USE OF DHA IN THE TREATMENT OF DYSLEXIA [Right-click to bookmark this link] | |||
Former [1997/22] | USE OF DHA AS A PHARMACEUTICAL COMPOSITION | ||
[2003/45] | Status | No opposition filed within time limit Status updated on 25.02.2005 Database last updated on 19.07.2024 | Most recent event Tooltip | 17.04.2015 | Change - lapse in a contracting state | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states N.V. Nutricia Stationsstraat 186 2712 HM Zoetermeer / NL | [N/P] |
Former [2002/37] | For all designated states N.V. Nutricia Stationsstraat 186 NL-2712 HM Zoetermeer / NL | ||
Former [2002/35] | For all designated states Nutricia N.V. Eerste Stationsstraat 186 2712 HM Zoetermeer / NL | ||
Former [1997/45] | For all designated states SCOTIA HOLDINGS PLC Weyvern House, Weyvern Park, Portsmouth Road, Peasmarsh Guildford GU3 1NA / GB | ||
Former [1997/22] | For all designated states SCOTIA HOLDINGS PLC Efamol House Woodbridge Meadows Guildford Surrey GU1 1BA / GB | Inventor(s) | 01 /
STORDY, Barbara Jacqueline Weyvern House, Weyvern Park, Portsmouth Road Peasmarsh, Guildford, Surrey GU3 1NA / GB | [1997/22] | Representative(s) | van Westenbrugge, Andries, et al Nederlandsch Octrooibureau P.O. Box 29720 NL-2502 LS The Hague / NL | [N/P] |
Former [2008/22] | van Westenbrugge, Andries, et al Postbus 29720 2502 LS Den Haag / NL | ||
Former [2003/16] | van Westenbrugge, Andries, et al Nederlandsch Octrooibureau P.O. Box 29720 2502 LS The Hague / NL | ||
Former [2002/35] | Hutter, Jacobus Johannes, et al Nederlandsch Octrooibureau P.O. Box 29720 2502 LS Den Haag / NL | ||
Former [1997/40] | Farwell, William Robert, et al PHILLIPS & LEIGH 7 Staple Inn High Holborn London WC1V 7QF / GB | ||
Former [1997/22] | Sturt, Clifford Mark, et al J. MILLER & CO. 34 Bedford Row, Holborn London WC1R 4JH / GB | Application number, filing date | 96919911.6 | 24.05.1996 | [1997/22] | WO1996GB01265 | Priority number, date | GB19950010636 | 25.05.1995 Original published format: GB 9510636 | [1997/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9637200 | Date: | 28.11.1996 | Language: | EN | [1996/52] | Type: | A1 Application with search report | No.: | EP0774962 | Date: | 28.05.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.11.1996 takes the place of the publication of the European patent application. | [1997/22] | Type: | B1 Patent specification | No.: | EP0774962 | Date: | 21.04.2004 | Language: | EN | [2004/17] | Search report(s) | International search report - published on: | EP | 28.11.1996 | Classification | IPC: | A61K31/202, A61K31/557, A61P25/00 | [2003/45] | CPC: |
A61K31/202 (EP,US);
A61K31/20 (EP,KR,US);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP)
| C-Set: |
A61K31/20, A61K2300/00 (US,EP);
A61K31/20, A61K31/20 (EP,US) |
Former IPC [1997/22] | A61K31/20, // (A61K31/20, 31:20) | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/22] | Title | German: | VERWENDUNG VON DHA IN DER BEHANDLUNG VON DYSLEXIE | [2003/45] | English: | USE OF DHA IN THE TREATMENT OF DYSLEXIA | [2003/45] | French: | UTILISATION DE L'ACIDE DOCOSAHEXANOIQUE (DHA)DANS LE TRAITEMENT DE LA DYSLEXIE | [2003/45] |
Former [1997/22] | VERWENDUNG VON DHA ALS PHARMAZEUTISCHES PRÄPARAT | ||
Former [1997/22] | USE OF DHA AS A PHARMACEUTICAL COMPOSITION | ||
Former [1997/22] | UTILISATION DE L'ACIDE DOCOSAHEXANOIQUE (DHA) EN TANT QUE COMPOSITION PHARMACEUTIQUE | Entry into regional phase | 29.01.1997 | National basic fee paid | 29.01.1997 | Designation fee(s) paid | 29.01.1997 | Examination fee paid | Examination procedure | 01.02.1997 | Examination requested [1997/22] | 25.09.2000 | Despatch of a communication from the examining division (Time limit: M04) | 26.01.2001 | Reply to a communication from the examining division | 10.04.2001 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2001 | Application deemed to be withdrawn, date of legal effect [2002/18] | 27.11.2001 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2002/18] | 05.07.2002 | Reply to a communication from the examining division | 18.11.2002 | Despatch of a communication from the examining division (Time limit: M04) | 17.02.2003 | Reply to a communication from the examining division | 02.05.2003 | Despatch of a communication from the examining division (Time limit: M04) | 24.07.2003 | Reply to a communication from the examining division | 22.10.2003 | Communication of intention to grant the patent | 18.02.2004 | Fee for grant paid | 18.02.2004 | Fee for publishing/printing paid | Opposition(s) | 24.01.2005 | No opposition filed within time limit [2005/15] | Request for further processing for: | 05.07.2002 | Request for further processing filed | 05.07.2002 | Full payment received (date of receipt of payment) Request granted | 08.11.2002 | Decision despatched | Fees paid | Renewal fee | 12.05.1998 | Renewal fee patent year 03 | 07.05.1999 | Renewal fee patent year 04 | 11.05.2000 | Renewal fee patent year 05 | 17.05.2001 | Renewal fee patent year 06 | 30.05.2002 | Renewal fee patent year 07 | 14.05.2003 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
Former [2007/16] | LU | 21.06.2004 | Cited in | International search | [Y]EP0599576 (SCOTIA HOLDINGS PLC [GB]) [Y] 1-9 * column W *; | [PY]EP0711503 (SCOTIA HOLDINGS PLC [GB]) [PY] 1-9* column W *; | [X] - HOLMAN ET AL, "ABNORMAL PLASMA LIPIDS OF PATIENTS WITH RETINITS PIGMENTOSA", LIPIDS, USA, vol. 29, no. 1, pages 61 - 65, XP000600054 [X] 1-9 * abstract * DOI: http://dx.doi.org/10.1007/BF02537092 | [PY] - HORROBIN ET AL, "POSSIBLE RELEVANCE OF PHOSPHOLIPID ABNORMALITIES AND GENETIC INTERACTIONS IN PSYCHIATRIC DISORDERS: THE RELATIONSHIP BETWEEN DYSLEXIA AND SCHIZOPHRENIA", MEDICAL HYPOTHESIS, USA, vol. 45, no. 6, pages 605 - 613, XP000600048 [PY] 1-9 * the whole document * DOI: http://dx.doi.org/10.1016/0306-9877(95)90246-5 | [PY] - M.MAKRIDES ET AL, "ARE LONG-CHIN POLYUNSATURATED FATTY ACIDS ESSENTIAL NUTRIENTS IN INFANCY?", LANCET, vol. 345, no. 8963, pages 1463 - 1468, XP000579670 [PY] 1-3 * the whole document * DOI: http://dx.doi.org/10.1016/S0140-6736(95)91035-2 |